NCT02239835View on ClinicalTrials.gov

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

November 30, 2001

Conditions
HIV Infections
Interventions
DRUG

Tipranavir (TPV) low dose

DRUG

Tipranavir (TPV) high dose

DRUG

Ritonavir low dose

DRUG

Ritonavir high dose

DRUG

Saquinavir

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02239835 - Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients | Biotech Hunter | Biotech Hunter